We are proud to announce the successful closure of Kaminari Medical’s €3.8M funding round. The round includes €2.3M in investments from Graduate Entrepreneur Fund, NLC Health Ventures, Libertatis Ergo Holding B.V. (Leiden University), and Demcon investment. Additionally, it was supported by a €1.5M Innovation Credit from the Netherlands Enterprise Agency (Rijksdienst voor Ondernemend Nederland (RVO)). Kaminari Medical uses intravascular imaging technology that leverages the power of photoacoustics and ultrasound to provide real-time qualification of plaque composition in CAD, particularly lipid-rich plaques that pose the greatest risk of rupture. This solution aims to deliver highly accurate assessments of coronary arteries to enable physicians to better assess the risk of major cardiovascular events, guide optimal treatment strategy, and save lives. With this strategic investment, Kaminari Medical will accelerate the development of their technology platform, allowing them to initiate clinical trials and prepare for market introduction. F.INSTITUTE acted as financial advisor for the transaction. #MedTech #Innovation #VentureCapital
F.INSTITUTE
Financiële diensten
Rotterdam, ZH 1.192 volgers
Full Service Finance and Capital Advisory for Front Runners in Life Sciences & Health, Biotech, Clean Tech and Deep Tech
Over ons
WHO ARE WE? As F.INSTITUTE offer a full financial service towards life science and deep tech ventures looking to scale up their business model. We provide excellent financial management solutions and work closely with management and business owners, acting as an integral financial team within the company. We help ambitious ventures grow. WHAT DO WE DO? We help you set up your company’s administration, planning and control processes and financials management correctly from the start. In addition to our administration and planning and control processes, we help clients take their businesses to the next level by accessing new and additional capital (financial management). Our services our focused on getting a company fully investor-ready and secure a funding structure that fits around the business’ revenue model. We maintain strong relationships with a broad range of strategic and financial investors, enabling us to find the right capital partner that will support your growth strategy. OUR SERVICES - Planning & Control - Accounting - CFO support - Capital raising - M&A Licensing - Valuation - Exiting WHY US? SME enterprises with big ambitions need heavyweight financial expertise to stay ahead of the pack. On your journey to success, you need a true partner. Who helps you from start to exit. We understand your business and know the drill. We are always happy to support and guide you in your growth path to success, by bringing in exactly the right people with the right expertise at the right time. ☎ +31 (0) 85 065 4500
- Website
-
https://www.f.institute
Externe link voor F.INSTITUTE
- Branche
- Financiële diensten
- Bedrijfsgrootte
- 11 - 50 medewerkers
- Hoofdkantoor
- Rotterdam, ZH
- Type
- Particuliere onderneming
- Opgericht
- 2008
- Specialismen
- Financial Management, Venture Capital, Planning and Control, Fractional CFO, Management Accounting, Corporate Finance, Payrolling, Subsidy Management , Dilutive Funding, Non-Dilutive Funding, Life Sciences, Medical Devices , Accounting, Capital Advisory, Annual Reporting, Growth Equity, Banking/IBSK, Investor Pitch en Fund Administration
Locaties
-
Primair
Routebeschrijving
Stationsplein 45
4th floor
Rotterdam, ZH 3013 AK, NL
-
Routebeschrijving
Rondweg 50
Zegveld, Utrecht 3474, NL
-
Routebeschrijving
St. John's Innovation Park, Cowley Road
Cambridge, CB4 OWS, GB
Medewerkers van F.INSTITUTE
-
Marlon Dijkshoorn
Founding Partner at F.INSTITUTE
-
Erik Kok QC
Controller at F.INSTITUTE
-
Jonathan Rohll
Independent Consultant and Advisor to early stage Biotech and Medtech companies, specialising in investment readiness and ecosystem connectivity.
-
Anastasia Grushko
Associate Accounting at F.INSTITUTE
Updates
-
Client in the spotlight: Spatium Medical Raises €5 million for smart insufflation technology We congratulate Spatium Medical on securing €5 million in their latest financing round. This funding enables the expansion of their innovative smart insufflation technology in operating theatres across Europe and the USA. As a financial partner, we worked closely with Spatium Medical, providing strategic financing support to help make this round a success. Congratulations to the team for reaching this milestone! We are proud to support this innovative company on their journey to disrupt the MedTech industry. #ClientSuccess #MedTech #LifeSciences #FinancialServices
Spatium Medical B.V. closes €5 Million financing round to bring smart insufflation technology to operating theatres in Europe and the USA. Rotterdam-based company Spatium Medical B.V., a pioneering MedTech spinoff from Erasmus MC, has successfully closed a €5 million financing round. This round includes new investors InnovationQuarter and Demcon Investment Fund and two of our existing investors: Van Herk Groep Ventures and Swanbridge Capital. The financing round is made possible with the continued support from Technology Transfer Office (TTO) – Erasmus MC and with the Innovation Credit from the Netherlands Enterprise Agency (RVO). Since the 1990’s, the number of laparoscopic surgeries has been ever growing, drastically reducing patient recovery time. However, the use of pressurized CO2 gas to create workspace for the surgeon, is not without consequences. Spatium Medical provides a solution by bringing smart, personalised insufflation to the world of laparoscopy. The unique features of Spatium Medical’s product enable the surgeon to choose the right pressure for each individual patient, lowering the burden and reducing recovery time. It ensures stability of the surgical workspace, improving safety during the procedure. On top of that, it adjusts to mechanical ventilation. In other words, the technology is “breathing with the patient”, reducing patient burden and lowering the risk of complications. This financing round will allow Spatium Medical to finalise the development of the smart insufflation device and to complete clinical studies in a number of hospitals. This will result in the certified product that will give patients access to improved surgical outcomes. Spatium Medical, recently incorporated in March 2022, is aiming to launch the innovative product in 2026. Willem Mees van der Bijl, CEO of Spatium Medical: The collaboration between the new and existing investors, the Netherlands Enterprise Agency (RVO) team and the Spatium Medical team has been invaluable. Not only in closing this important financial round, but also in sharing knowledge and expertise. This enables us to bring this innovative technology, developed here in Rotterdam, to the point where it will become the next standard of care for minimal invasive surgeries worldwide. Very exciting! Many thanks to all new and existing investors Van Herk Groep; Swanbridge Capital; InnovationQuarter; UNIIQ - Finance for the Future; Erasmus MC; Human Plus Fund; IDE Group; Demcon; Netherlands Enterprise Agency
-
-
🚀 We’re excited to announce that F.INSTITUTE will be attending OBN (UK) Ltd BioForward 2024 in Oxford on 24th September! 🌿💡 Join our team, Jonathan Rohll and Jordy Breuker, as they connect with the brightest innovators in the life sciences industry. 🚀 Linked to our gold sponsorship, Jordy will also be leading a workshop on Early Stage Finance, providing key insights for scaling businesses in the sector. Looking forward to meaningful discussions, collaborations, and exploring new opportunities with fellow attendees. Let’s connect in person to talk about how we can support your growth journey! #BioForward2024 #LifeSciences #Finance #Innovation #Networking #FInstitute #ScaleUp
-
-
Thanks OBN (UK) Ltd ! Excited to support and be a part of this year's Biofoward! Looking forward to connecting with early-stage life sciences R&D companies and industry partners. See you there! #lifeSciences #innovation #event #growth
Momentum is building for #BioForward (Oxford, 24 September), OBN’s growth focused one-day exhibition event for early-stage life sciences R&D companies and the industry partners that support them. We wanted to spotlight and thank the following sponsors, whose support enables us to deliver on our mission to catalyse success across the life sciences industry. With thanks to: ⭐ Headline Venue Sponsor ⭐ Oxford Technology Park ⭐ Gold Sponsors ⭐ F-INSTITUTE Thermo Fisher Scientific ⭐ Silver Sponsors ⭐ Partners&. Medicilon Inc. ⭐ Corporate Media Partner ⭐ Zyme Communications Ltd ⭐ Media Supporters ⭐ Connect In Pharma Science & Engineering Health Technologies Alliance (SEHTA) If you’re keen to get involved as a sponsor, exhibitor (only 10 stands left!) or attendee, find out more here: https://lnkd.in/en3nYPpn or contact the events team at events@obn.org.uk
-
-
We’re thrilled to support this year's Summit as a sponsor! 🙌 Happy to make our contribution and looking forward to December. Join us in Bruges on 9-11 December to meet the F.INSTITUTE team along with other experts and investors, and connect with Europe's brightest healthtech stars! #healthtech #finance #summit2023 #innovation
We're so glad to have F-INSTITUTE onboard as a Sponsor for this year's Summit! 🙌 F.INSTITUTE is a full service finance boutique based in Rotterdam, The Netherlands, providing state-of-the-art financial services to clients in the life sciences and technology sector. Join us in Bruges on 9-11 December to meet with the F.INSTITUTE team and other finance experts and investors wanting to connect with Europe's brightest #healthtech stars! https://lnkd.in/e4rhJe8H #HTIS24 #investment #finance
-
-
Keeping up with the present developments, evolving financing landscape and their impact on medical innovations can be challenging. Discover everything you need to know about BioTech in this keynote from Lars Ottevanger, held at OBN (UK) Ltd Biotrinity in London in April 2024! Featuring insights and niche expertise, gain valuable knowledge to stay ahead in the BioTech industry. Read the full presentation now and reach out to Lars Ottevanger for tailored financial advice for your BioTech company.
-
On June 11th, we had the pleasure of kicking off our partnership with YES!Delft. Great attendance, good energy, and it was nice to exchange information about our services with such an enthusiastic audience. Thumbs up to the organisation! What's the next step in our partnership? Joining the Service Partner Session with startups from the latest Validation Lab Program on June 18th. Boris Polm and Jordy Breuker are looking forward to meeting and connecting with the newest YES!Delft startups there. #startups #partnership #gearupwiththebest
-
-
FREE white paper! (link in comment) Looking to fuel your growth? Venture debt offers an attractive alternative to equity, especially in today's market. Our latest white paper, "Opportunities in Europe’s Venture Debt Market," authored by Luc Schmitt, dives deep into venture debt and shares knowledge about: - Understand the evolving venture debt market and how it complements the equity landscape. - Learn about key deal terms, the application process, and strategic use cases. - Stay ahead with the latest data and trends shaping the venture debt landscape in Europe. A perfect read this weekend for startup founders, investors, and anyone interested in innovative financing solutions that drive growth without sacrificing equity. #VentureDebt #StartupFunding #GrowthWithoutDilution #EuropeanMarkets #InvestmentStrategies #FinanceForStartups
-
-
We are very excited to announce our new partnership with YES!Delft. Our mission is to partner with ambitious founders who are setting new industry standards and creating impactful technologies. At F.INSTITUTE we are looking forward to paving the way for the world's most ambitious companies to accomplish their big goals together with YES!Delft.
We are happy to announce a new partnership between YES!Delft and F-INSTITUTE! This collaboration combines our expertise in tech incubation with F-Institute’s financial management services for startups. Benefits for Startups: - Enhanced financial and advisory support - Comprehensive growth resources - Streamlined path from ideation to commercialization Together, we empower startups to achieve new heights in innovation and success. #Innovation #Partnership #YESDelft #FInstitute #Startups #Entrepreneurship
-
-
Yesterday we wrapped up OBN (UK) Ltd BioTrinity 2024. An extremely well-run event with a great mix of presentations, companies and innovation in the LifeScience sector. We enjoyed the insightful and intelligent talks and are grateful for the opportunity to create new connections in the UK ecosystem! #BTR24 #BioTrinity2024 #LifeSciences #BioTrinity
-